科研成果-九游会国际

on-treatment blood tmb as predictors for camrelizumab plus chemotherapy in advanced lung squamous cell carcinoma: biomarker analysis of a phase iii trial

germline hla-b evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer

perioperative ctdna-based molecular residual disease detection for non-small cell lung cancer: a prospective multicenter cohort study (lungca-1)

paclitaxel liposome for injection (lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: a multicenter, randomized, open-label, parallel controlled clinical study

nivolumab-associated dress in a genetic susceptible individual